Does USTEKINUMAB Cause Soft tissue infection? 19 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Soft tissue infection have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.0% of all adverse event reports for USTEKINUMAB.
19
Reports of Soft tissue infection with USTEKINUMAB
0.0%
of all USTEKINUMAB reports
2
Deaths
11
Hospitalizations
How Dangerous Is Soft tissue infection From USTEKINUMAB?
Of the 19 reports, 2 (10.5%) resulted in death, 11 (57.9%) required hospitalization, and 1 (5.3%) were considered life-threatening.
Is Soft tissue infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Soft tissue infection?
METHOTREXATE (129)
PREDNISONE (105)
CYCLOPHOSPHAMIDE (98)
RITUXIMAB (98)
MYCOPHENOLATE MOFETIL (81)
VINCRISTINE (76)
DEXAMETHASONE (70)
TACROLIMUS (68)
DOXORUBICIN (64)
CYCLOSPORINE (53)
Which USTEKINUMAB Alternatives Have Lower Soft tissue infection Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE